Skip to content

Clinical trials

Completed Macular Degeneration trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: Canada Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20073
20081
20093
20102
20115
20122
20133
20143
20153
20162
20194
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's6
Bayer4
University Health Network, Toronto4
Novartis Pharmaceuticals3
GlaxoSmithKline2
McMaster University2
Regeneron Pharmaceuticals2
Allergan1
Amgen1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration40
Geographic Atrophy6
Choroidal Neovascularization4
Vision Disorders4
Retinal Detachment2
Retinal Vein Occlusion2
Wet Macular Degeneration2
Disease1
Eye Diseases1
Glaucoma1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.